Prana Biotechnology (PRAN)

[stockjuicer]

News out: Classen manipulation in play!

First Cramer and his minions do a hatchet job to Galena now Classen trying his best. Stock dives since yesterday and no news anywhere until now? Gimme a break. We got Huntington's results and more still coming. Still long!

Prana Biotech -13% as analyst casts doubts on PBT2 data
Monday, February 10, 11:31 AM ET | PRAN
Prana Biotechnology (PRAN -13.2%) plunges following negative comments from Sumner Street analyst Bart Classen, who isn't impressed with data from PRAN's PBT2 treatment for Alzheimer's and Huntington’s diseases.
Although a 12-week trial showed improvement in some components of the neuropsychological test battery, the firm believes the results are not statistically significant when one adjusts for using multiple endpoints and is skeptical that the results will add clarity to the question of efficacy in Alzheimer's patients.